What's the next big money short squeeze like we're seeing in GameStop (GME)?
January 27, 2021 -- InvestorsHub NewsWire -- via WallStreet
Visions -- Don’t worry if you missed out, the short squeeze on
GameStop (GME) was a combination of events that you can follow in
other stocks. You just have to know where to look. Here’s some we
found could have similar explosive returns.
THC Therapeutics, Inc. (THCT), a
forward-thinking, publicly-traded technology company, whose mission
statement is, "Better Health through the Science of Nature,".
On January, 12th of this year, just a couple of short weeks
ago it appears $THCT has possibly encountered large
naked shorting by institutions. According to FINRA REG SHO data we
believe there are up to 5 million shares short of $THCT. That’s
near half of their float.
This is typical of companies that are often seeing great returns
quickly for investors but aren’t seen as traditional long term
investments because of their sector, stock price and/or liquidity.
Most short sellers aren’t even looking at the fundamentals of the
company. Clearly they don’t understand the massive potential in
THCT. “Naked short selling” is not only illegal but also much more
dangerous than an average short sale. Either way, shorting is risky
and can backfire like it has with GameStop (GME)
shorters. If these shares are found to be illegal shorts it could
send the stock flying. Obviously the company is on top of it and
knows where to point. Expect to see lots of green if this all
Other companies that have made massive gains for investors and
could be targeted;
OPTEC International, Inc. (OPTI)
a developer and manufacturer of electronic LED, Ultraviolet (UV)
& UV-C safety products and related advanced technologies and
PPE (Personal Protection Equipment) products. The company's
Safe-Scan product line is being launched at a time when HR
directors and facilities managers are experiencing extreme concern
with respect to keeping environments safe during the global
pandemic crisis and the safe reopening of the U.S. economy.
Bionano Genomics, Inc. (Nasdaq:
BNGO) a genome analysis company providing tools and
services based on its Saphyr system to scientists and clinicians
conducting genetic research and patient testing and providing
diagnostic testing for those with autism spectrum disorder (ASD)
and other neurodevelopmental disabilities through its Lineagen
Tesoro Enterprises, Inc. (OTCMKT:
TSNP), which will soon be renamed HUMBL, Inc.
HUMBL is a new, Web 3 platform that seamlessly connects
consumers and merchants in the digital economy. HUMBL uses new
technologies like blockchain to deliver the HUMBL® Pay Mobile
Wallet, HUMBL Studios™ online merchant listings and HUMBL
Financial™ services products.
This article was written by WallStreet Visions, LLC (“WallStreet
Visions”). WallStreet Visions may have a position in
the securities mentioned in this article at the time of
publication, and may increase or decrease its position without
notice. This article is based on public information and the
opinions of WallStreet Visions. WallStreet Visions was paid
fifteen-hundred dollars by THC Therapeutics, Inc. for this
article. This article contains forward-looking statements
that are subject to certain risks and uncertainties that could
cause actual results to differ materially from any results
predicted herein. WallStreet Visions is not registered with
any financial or securities regulatory authority, and does not
provide or claim to provide investment advice.
Contact Information: 1-585-734-6630
Company Name: WallStreet Visions
Contact Person: Media Manager
SOURCE: WallStreet Visions